Effect of Resveratrol on the intestinal microbiota in Type2 diabetes Mellitus mice
- 2 December 2024
- journal article
- research article
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 56 (1) , 447-463
Abstract
Some natural products have been found to have a positive effect on the treatment of Type 2 Diabetes Mellitus (T2DM). The effective mechanism by which these natural products work may be attributed to their ability to alter the gut microbiome. In this study, considering the beneficial properties of resveratrol for T2DM, the mechanism of resveratrol in releasing of T2DM, the correlation between the apparent traits of resveratrol in T2DM mice and the changes in intestinal flora structure were explored. The intervention of resveratrol in different dose did effectively improve the apparent T2DM symptoms in mice, including reduced fasting blood glucose, enhance to both the insulin tolerance and glucose tolerance. Simultaneously, resveratrol can effectively ameliorate the pathological condition of the colon and rectum in T2DM mice, leading to a reduction in intestinal villi swelling and fat vacuoles. The intervention of resveratrol led to changes in the gut flora structure of T2DM mice. Erysipelas and Ileibacterium are crucial taxa of resveratrol involved in maintaining the balance of the gut microbiota. The abundance of Erysipelotrichaceae and Ileibacterium was significantly elevated under the treatment of resveratrol, and the compose of the gut microbiota was more inclined to healthy mice. T2DM symptoms could be alleviated by resveratrol through different mechanisms compared to metformin intervention.Keywords
Funding Information
- The National Natural Science Foundation of China funded project (82060149)
- the basic research foundation of Science and Technology Department of Yunnan Province (202201AT070008, 202101BA070001-112)
This publication has 29 references indexed in Scilit:
- Historical review of the diagnosis of prediabetes/intermediate hyperglycemia: Case for the international criteriaDiabetes Research and Clinical Practice, 2022
- Jia Wei Xiao Yao San ameliorates chronic stress-induced depression-like behaviors in mice by regulating the gut microbiome and brain metabolome in relation to purine metabolismPhytomedicine, 2022
- Resveratrol (RV): A pharmacological review and call for further researchBiomedicine & Pharmacotherapy, 2021
- Botanical Interventions to Improve Glucose Control and Options for Diabetes TherapySN Comprehensive Clinical Medicine, 2021
- Gut microbiota changes in patients with autism spectrum disordersJournal of Psychiatric Research, 2020
- Lonicera caerulea L. Polyphenols Alleviate Oxidative Stress‐Induced Intestinal Environment Imbalance and Lipopolysaccharide‐Induced Liver Injury in HFD‐Fed Rats by Regulating the Nrf2/HO‐1/NQO1 and MAPK PathwaysMolecular Nutrition & Food Research, 2020
- Biosynthesis of resveratrol and piceatannol in engineered microbial strains: achievements and perspectivesApplied Microbiology and Biotechnology, 2019
- The molecular targets of resveratrolBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2015
- Diet Dominates Host Genotype in Shaping the Murine Gut MicrobiotaCell Host & Microbe, 2015
- Benefits of polyphenols on gut microbiota and implications in human healthThe Journal of Nutritional Biochemistry, 2013